These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 9441076

  • 1. Two-step tuberculin skin testing of injection drug users recruited from community-based settings.
    Lifson AR, Grant SM, Lorvick J, Pinto FD, He H, Thompson S, Keudell EG, Stark MJ, Booth RE, Watters JK.
    Int J Tuberc Lung Dis; 1997 Apr; 1(2):128-34. PubMed ID: 9441076
    [Abstract] [Full Text] [Related]

  • 2. Tuberculin skin testing in intravenous drug users: differences between HIV-seropositive and HIV-seronegative subjects.
    Portu JJ, Aldamiz-Etxebarria M, Agud JM, Arévalo JM, Almaraz MJ, Ayensa C.
    Addict Biol; 2002 Apr; 7(2):235-41. PubMed ID: 12006219
    [Abstract] [Full Text] [Related]

  • 3. Yield of tuberculin screening among injection drug users.
    Brassard P, Bruneau J, Schwartzman K, Sénécal M, Menzies D.
    Int J Tuberc Lung Dis; 2004 Aug; 8(8):988-93. PubMed ID: 15305482
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prevalence of Mycobacterium tuberculosis infection among injection drug users in Toronto.
    Rusen ID, Yuan L, Millson ME.
    CMAJ; 1999 Mar 23; 160(6):799-802. PubMed ID: 10189423
    [Abstract] [Full Text] [Related]

  • 6. Agreement between Mantoux skin testing and QuantiFERON-TB assay using dual mycobacterial antigens in current and former injection drug users.
    Shah SS, McGowan JP, Klein RS, Converse PJ, Blum S, Gourevitch MN.
    Med Sci Monit; 2006 Apr 23; 12(4):MT11-6. PubMed ID: 16572060
    [Abstract] [Full Text] [Related]

  • 7. Utility of tuberculin and anergy skin testing in predicting tuberculosis infection in human immunodeficiency virus-infected persons in Thailand.
    Yanai H, Uthaivoravit W, Mastro TD, Limpakarnjanarat K, Sawanpanyalert P, Morrow RH, Nieburg P.
    Int J Tuberc Lung Dis; 1997 Oct 23; 1(5):427-34. PubMed ID: 9441097
    [Abstract] [Full Text] [Related]

  • 8. [Tuberculin test in HIV infection].
    Portu JJ, Pérez JR, Arévalo JM, Aldamiz-Etxebarria M, Agud JM, Ayensa C.
    Enferm Infecc Microbiol Clin; 1996 Feb 23; 14(2):90-5. PubMed ID: 8714155
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Increasing the use of bleach and condoms among injecting drug users in Denver: outcomes of a targeted, community-level HIV prevention program.
    Rietmeijer CA, Kane MS, Simons PZ, Corby NH, Wolitski RJ, Higgins DL, Judson FN, Cohn DL.
    AIDS; 1996 Mar 23; 10(3):291-8. PubMed ID: 8882669
    [Abstract] [Full Text] [Related]

  • 11. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.
    Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, Walker AT, Friedland GH.
    N Engl J Med; 1989 Mar 02; 320(9):545-50. PubMed ID: 2915665
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison between a whole blood interferon-gamma release assay and tuberculin skin testing for the detection of tuberculosis infection among patients at risk for tuberculosis exposure.
    Kimura M, Converse PJ, Astemborski J, Rothel JS, Vlahov D, Comstock GW, Graham NM, Chaisson RE, Bishai WR.
    J Infect Dis; 1999 May 02; 179(5):1297-300. PubMed ID: 10191241
    [Abstract] [Full Text] [Related]

  • 14. Lack of direct correlation between CD4 T-lymphocyte counts and induration sizes of the tuberculin skin test in human immunodeficiency virus type 1 seropositive patients.
    Diagbouga S, Fumoux F, Ledru E, Sanou PT, Barro D, Marchal G.
    Int J Tuberc Lung Dis; 1998 Apr 02; 2(4):317-23. PubMed ID: 9559403
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevalence of HIV and hepatitis B and self-reported injection risk behavior during detention among street-recruited injection drug users in Los Angeles County, 1994-1996.
    López-Zetina J, Kerndt P, Ford W, Woerhle T, Weber M.
    Addiction; 2001 Apr 02; 96(4):589-95. PubMed ID: 11300962
    [Abstract] [Full Text] [Related]

  • 17. Two-step tuberculin skin testing in drug users.
    Swaminathan S, Schoenbaum EE, Klein RS, Howard AA, Lo Y, Gourevitch MN.
    J Addict Dis; 2007 Apr 02; 26(2):71-9. PubMed ID: 17595000
    [Abstract] [Full Text] [Related]

  • 18. Mycobacterium tuberculosis infection among crack and injection drug users in San Juan, Puerto Rico.
    Reyes JC, Robles RR, Colón HM, Marrero CA, Castillo X, Meléndez M.
    P R Health Sci J; 1996 Sep 02; 15(3):233-6. PubMed ID: 8994290
    [Abstract] [Full Text] [Related]

  • 19. An alternative to 'two-step' tuberculin skin testing for Southeast Asian refugees.
    Wenzel M.
    Nurse Pract; 1991 Sep 02; 16(9):25-8. PubMed ID: 1945074
    [Abstract] [Full Text] [Related]

  • 20. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
    Jansà JM, Serrano J, Caylà JA, Vidal R, Ocaña I, Español T.
    Int J Tuberc Lung Dis; 1998 Feb 02; 2(2):140-6. PubMed ID: 9580481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.